BACKGROUND AND PURPOSE: ISRs remain a major issue in the endovascular
management of ICAD, requiring retreatment by reangioplasty. The aim of the present study …

Background Randomized clinical trials have failed to prove that the safety and efficacy of
endovascular treatment for symptomatic intracranial atherosclerotic disease (ICAD) is better …

Introduction We assessed the technical feasibility of balloon-assisted angioplasty with
consecutive stenting using a flexible, self-expanding neurovascular stent for the treatment of …

The endovascular treatment of atherosclerotic intracranial arterial stenoses has previously
been based on balloon dilatation or the deployment of a balloon expandable stent. Both …

BACKGROUND Conventional stent-based angioplasty was challenged for the high
incidence of perioperative complications and follow-up in-stent restenosis (ISR) in treating …

Background The optimal treatment for patients with symptomatic severe intracranial
atherosclerotic disease is not well established. Angioplasty and stenting have been …

Objectives Intracranial arteriosclerotic disease is a relevant cause of ischemic stroke
worldwide with a high recurrence rate despite best medical treatment. Following the …

Object The limitations of the medical management of symptomatic intracranial arterial
stenosis (SIAS) have encouraged the development of new strategies, such as endovascular …

Background Drug-coated balloon (DCB) angioplasty has been studied for reducing the
occurrence of restenosis after treatment for intracranial atherosclerotic stenosis (ICAS), but …

Background and purpose Endovascular treatment is offered for symptomatic intracranial
stenosis (ICS) when medical therapy fails. The purpose of this meta-analysis is to evaluate …